Despite sharing histologic and molecular features with SCLC (such as TP53 and RB1 loss), NEPC retains many of the early genomic alterations that arise in prostate cancer [e.g., TMPRSS2-ERG gene rearrangement (4, 9, 11, 15–19)]. Here, RB1 is linked to prostate cancer.